Endo International PLC (DELISTED) (ENDPQ:DL)
0.0006
0.00 (0.00%)
USD |
OTCM |
May 01, 16:00
Endo International Cash from Financing (Quarterly): -149.76M for Dec. 31, 2023
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | -149.76M |
September 30, 2023 | -157.80M |
June 30, 2023 | -152.36M |
March 31, 2023 | -144.72M |
December 31, 2022 | -146.55M |
September 30, 2022 | -170.37M |
June 30, 2022 | -7.752M |
March 31, 2022 | -189.20M |
December 31, 2021 | -29.94M |
September 30, 2021 | -9.789M |
June 30, 2021 | -18.40M |
March 31, 2021 | -47.35M |
December 31, 2020 | -10.21M |
September 30, 2020 | -22.63M |
June 30, 2020 | -61.25M |
March 31, 2020 | -14.48M |
December 31, 2019 | -14.96M |
September 30, 2019 | -15.36M |
June 30, 2019 | 268.70M |
March 31, 2019 | -33.77M |
December 31, 2018 | -18.76M |
September 30, 2018 | -22.02M |
June 30, 2018 | -17.38M |
March 31, 2018 | -23.41M |
December 31, 2017 | -31.64M |
Date | Value |
---|---|
September 30, 2017 | -35.77M |
June 30, 2017 | -46.39M |
March 31, 2017 | -53.19M |
December 31, 2016 | -62.68M |
September 30, 2016 | -32.91M |
June 30, 2016 | -262.95M |
March 31, 2016 | -38.65M |
December 31, 2015 | -568.55M |
September 30, 2015 | 3.454B |
June 30, 2015 | 2.120B |
March 31, 2015 | 996.86M |
December 31, 2014 | -9.848M |
September 30, 2014 | -30.10M |
June 30, 2014 | 240.41M |
March 31, 2014 | 102.40M |
December 31, 2013 | 680.00M |
September 30, 2013 | 6.467M |
June 30, 2013 | 4.01M |
March 31, 2013 | -110.95M |
December 31, 2012 | -136.77M |
September 30, 2012 | -208.64M |
June 30, 2012 | -48.01M |
March 31, 2012 | -252.12M |
December 31, 2011 | -149.04M |
September 30, 2011 | -408.12M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-189.20M
Minimum
Mar 2022
268.70M
Maximum
Jun 2019
-57.59M
Average
-29.94M
Median
Dec 2021
Cash from Financing (Quarterly) Benchmarks
Alkermes PLC | -17.87M |
Jazz Pharmaceuticals PLC | -56.55M |
Medtronic PLC | -1.50B |
Perrigo Co PLC | -60.40M |
Iterum Therapeutics PLC | 7.217M |
Cash from Financing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | 115.06M |
Cash from Investing (Quarterly) | -11.65M |
Free Cash Flow | 340.77M |
Free Cash Flow Per Share (Quarterly) | 0.4038 |
Free Cash Flow to Equity (Quarterly) | 7.484B |
Free Cash Flow to Firm (Quarterly) | 94.98M |
Free Cash Flow Yield | 241.5K% |